227 related articles for article (PubMed ID: 9988241)
1. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?
Shafer MA; Pantell RH; Schachter J
Arch Pediatr Adolesc Med; 1999 Feb; 153(2):119-25. PubMed ID: 9988241
[TBL] [Abstract][Full Text] [Related]
2. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.
Howell MR; Quinn TC; Brathwaite W; Gaydos CA
Sex Transm Dis; 1998 Feb; 25(2):108-17. PubMed ID: 9518379
[TBL] [Abstract][Full Text] [Related]
3. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Sexually Transmitted Infection Screening for Adolescents and Young Adults in the Pediatric Emergency Department.
Eckman MH; Reed JL; Trent M; Goyal MK
JAMA Pediatr; 2021 Jan; 175(1):81-89. PubMed ID: 33136149
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of a school-based sexually transmitted disease screening program.
Wang LY; Burstein GR; Cohen DA
Sex Transm Dis; 2002 Dec; 29(12):737-45. PubMed ID: 12466713
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting.
Blake DR; Maldeis N; Barnes MR; Hardick A; Quinn TC; Gaydos CA
Sex Transm Dis; 2008 Jul; 35(7):649-55. PubMed ID: 18461013
[TBL] [Abstract][Full Text] [Related]
7. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
Blackwell AL; Thomas PD; Wareham K; Emery SJ
Lancet; 1993 Jul; 342(8865):206-10. PubMed ID: 8100930
[TBL] [Abstract][Full Text] [Related]
8. Acute pelvic inflammatory disease.
Eschenbach DA
Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens.
van Valkengoed IG; Postma MJ; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928
[TBL] [Abstract][Full Text] [Related]
10. Chlamydial pelvic inflammatory disease.
Paavonen J; Lehtinen M
Hum Reprod Update; 1996; 2(6):519-29. PubMed ID: 9111185
[TBL] [Abstract][Full Text] [Related]
11. Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial.
Tamarelle J; Thiébaut ACM; Sabin B; Bébéar C; Judlin P; Fauconnier A; Rahib D; Méaude-Roufai L; Ravel J; Morré SA; de Barbeyrac B; Delarocque-Astagneau E;
Trials; 2017 Nov; 18(1):534. PubMed ID: 29132441
[TBL] [Abstract][Full Text] [Related]
12. The clinical and economic consequences of screening young men for genital chlamydial infection.
Ginocchio RH; Veenstra DL; Connell FA; Marrazzo JM
Sex Transm Dis; 2003 Feb; 30(2):99-106. PubMed ID: 12567164
[TBL] [Abstract][Full Text] [Related]
13. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.
Howell MR; Quinn TC; Gaydos CA
Ann Intern Med; 1998 Feb; 128(4):277-84. PubMed ID: 9471930
[TBL] [Abstract][Full Text] [Related]
14. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial.
Aghaizu A; Adams EJ; Turner K; Kerry S; Hay P; Simms I; Oakeshott P
Sex Transm Infect; 2011 Jun; 87(4):312-7. PubMed ID: 21444333
[TBL] [Abstract][Full Text] [Related]
15. Time from sexually transmitted infection acquisition to pelvic inflammatory disease development: influence on the cost-effectiveness of different screening intervals.
Smith KJ; Cook RL; Roberts MS
Value Health; 2007; 10(5):358-66. PubMed ID: 17888100
[TBL] [Abstract][Full Text] [Related]
16. Acute pelvic inflammatory disease.
Freij BJ
Semin Adolesc Med; 1986 Jun; 2(2):143-53. PubMed ID: 3602634
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
Blake DR; Gaydos CA; Quinn TC
Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
[TBL] [Abstract][Full Text] [Related]
18. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies.
Herzog SA; Heijne JC; Althaus CL; Low N
Sex Transm Dis; 2012 Aug; 39(8):628-37. PubMed ID: 22801346
[TBL] [Abstract][Full Text] [Related]
19. Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease.
Sufrin CB; Postlethwaite D; Armstrong MA; Merchant M; Wendt JM; Steinauer JE
Obstet Gynecol; 2012 Dec; 120(6):1314-21. PubMed ID: 23168755
[TBL] [Abstract][Full Text] [Related]
20. Subsequent sexually transmitted infection after outpatient treatment of pelvic inflammatory disease.
Trent M; Chung SE; Forrest L; Ellen JM
Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1022-5. PubMed ID: 18981349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
